Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21558517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
Condition: Acute ST Elevation Myocardial Infarction
Interventions: Drug: Epoietin Alfa;   Drug: Placebo
2 Enrolling by invitation Erythropoietin Effect on ischemic_ Reperfusion Injury in Cronary Artery Bypass Graft Surgery
Condition: Myocardial Ischemic Reperfusion Injury
Interventions: Drug: normal saline;   Drug: erythropoietin

Study has passed its completion date and status has not been verified in more than two years.